Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression

Br J Cancer. 1987 Oct;56(4):425-32. doi: 10.1038/bjc.1987.218.

Abstract

A flow cytometric technique has been established for accurately quantitating the cell surface density of MHC antigens and the percentage of cells expressing MHC antigens in 38 colorectal tumours. Thirty-four percent of tumours were partially or completely negative for HLA-ABC antigen expression. Although the quantity of HLA-ABC antigens varied widely, there was no correlation between the density of HLA-ABC antigens, or the percentage of cells expressing these antigens and clinicopathological stage. Fifty percent of the colorectal tumours expressed HLA-DR with varying antigen densities. All of the poorly differentiated tumours expressed HLA-DR but there was no correlation between expression of HLA-DR and clinicopathological stage. The aneuploid tumours expressed more HLA-ABC and HLA-DR antigens on a higher percentage of cells than the diploid tumours. Abnormal expression of the tumour associated antigens CEA, Y haptenic blood group and 791T p72 also correlated with expression of HLA-ABC and HLA-DR antigens on colorectal tumours. The majority of early derived in vitro dividing cells failed to express both HLA-ABC and HLA-DR antigens although they expressed high levels of tumour associated antigens. If there is a correlation between in vitro and in vivo growth perhaps tumours are maintained and seeded by MHC antigen negative cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / immunology
  • Colonic Neoplasms / immunology*
  • Colonic Neoplasms / pathology
  • Flow Cytometry
  • HLA Antigens / immunology*
  • HLA-DR Antigens / immunology
  • Humans
  • Neoplasm Staging
  • Rectal Neoplasms / immunology*
  • Rectal Neoplasms / pathology

Substances

  • Antigens, Neoplasm
  • HLA Antigens
  • HLA-DR Antigens